tradingkey.logo
tradingkey.logo
Pesquisar

Tactile Systems Technology Inc

TCMD
Adicionar à lista de desejos
22.740USD
-0.300-1.30%
Fechamento 05/15, 16:00ETCotações atrasadas em 15 min
512.93MValor de mercado
25.79P/L TTM

Tactile Systems Technology Inc

22.740
-0.300-1.30%

Mais detalhes de Tactile Systems Technology Inc Empresa

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.

Informações de Tactile Systems Technology Inc

Código da empresaTCMD
Nome da EmpresaTactile Systems Technology Inc
Data de listagemJul 28, 2016
CEODodd (Sheri L)
Número de funcionários1037
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 28
Endereço3701 Wayzata Blvd, Suite 300
CidadeMINNEAPOLIS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55416
Telefone18333822845
Sitehttps://www.tactilemedical.com/
Código da empresaTCMD
Data de listagemJul 28, 2016
CEODodd (Sheri L)

Executivos da empresa Tactile Systems Technology Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Raymond O. (Ray) Huggenberger
Mr. Raymond O. (Ray) Huggenberger
Independent Director
Independent Director
62.84K
+10.38%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Chairman of the Board
Independent Chairman of the Board
55.04K
+11.85%
Ms. Elaine M. Birkemeyer
Ms. Elaine M. Birkemeyer
Chief Financial Officer
Chief Financial Officer
51.57K
-17.08%
Ms. Carmen B. Volkart
Ms. Carmen B. Volkart
Independent Director
Independent Director
44.22K
+14.75%
Ms. Sheri L. Dodd
Ms. Sheri L. Dodd
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Kristie T. Burns
Ms. Kristie T. Burns
Senior Vice President - Marketing and Clinical Affairs
Senior Vice President - Marketing and Clinical Affairs
--
--
Ms. Valerie L. (Val) Asbury
Ms. Valerie L. (Val) Asbury
Independent Director
Independent Director
--
--
Mr. D. Brent Shafer
Mr. D. Brent Shafer
Independent Director
Independent Director
--
--
Dr. B. Vindell Washington, M.D.
Dr. B. Vindell Washington, M.D.
Independent Director
Independent Director
--
--
Mr. Sam Bentzinger
Mr. Sam Bentzinger
Investor Relations Contact Officer
Investor Relations Contact Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Raymond O. (Ray) Huggenberger
Mr. Raymond O. (Ray) Huggenberger
Independent Director
Independent Director
62.84K
+10.38%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Chairman of the Board
Independent Chairman of the Board
55.04K
+11.85%
Ms. Elaine M. Birkemeyer
Ms. Elaine M. Birkemeyer
Chief Financial Officer
Chief Financial Officer
51.57K
-17.08%
Ms. Carmen B. Volkart
Ms. Carmen B. Volkart
Independent Director
Independent Director
44.22K
+14.75%
Ms. Sheri L. Dodd
Ms. Sheri L. Dodd
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Kristie T. Burns
Ms. Kristie T. Burns
Senior Vice President - Marketing and Clinical Affairs
Senior Vice President - Marketing and Clinical Affairs
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2023
Por EmpresaUSD
Nome
Receita
Proporção
Lymphedema products
278.38M
84.48%
Airway clearance products
51.14M
15.52%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Lymphedema products
278.38M
84.48%
Airway clearance products
51.14M
15.52%

Distribuição de ações

Atualizado em: qua, 13 de mai
Atualizado em: qua, 13 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
6.83%
Morgan Stanley & Co. LLC
5.34%
Nomura Investment Management Business Trust
5.33%
Cadian Capital Management LP
4.81%
Dimensional Fund Advisors, L.P.
4.79%
Outro
72.90%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
6.83%
Morgan Stanley & Co. LLC
5.34%
Nomura Investment Management Business Trust
5.33%
Cadian Capital Management LP
4.81%
Dimensional Fund Advisors, L.P.
4.79%
Outro
72.90%
Tipos de investidores
Investidores
Proporção
Investment Advisor
43.16%
Investment Advisor/Hedge Fund
38.32%
Hedge Fund
10.28%
Research Firm
7.16%
Individual Investor
2.33%
Pension Fund
0.69%
Bank and Trust
0.42%
Family Office
0.31%
Venture Capital
0.10%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
376
24.21M
107.32%
-2.56M
2025Q4
351
22.70M
101.64%
-5.48M
2025Q3
366
22.60M
101.18%
-8.77M
2025Q2
389
24.67M
110.65%
-7.05M
2025Q1
401
24.00M
103.20%
-7.47M

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
1.54M
6.77%
-82.94K
-5.11%
Dec 31, 2025
Morgan Stanley & Co. LLC
1.20M
5.3%
-913.29K
-43.12%
Dec 31, 2025
Nomura Investment Management Business Trust
1.20M
5.29%
--
--
Mar 09, 2026
Cadian Capital Management LP
1.08M
4.77%
-971.66K
-47.27%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
1.10M
4.81%
-95.97K
-8.06%
Dec 31, 2025
Acadian Asset Management LLC
956.07K
4.2%
+110.62K
+13.08%
Dec 31, 2025
Paradigm Capital Management, Inc.
736.60K
3.24%
-801.80K
-52.12%
Dec 31, 2025
Arrowstreet Capital, Limited Partnership
638.37K
2.81%
+529.37K
+485.65%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Cambria Micro and SmallCap Shareholder Yield ETF
1.13%
Invesco NASDAQ Future Gen 200 ETF
0.61%
First Trust Active Factor Small Cap ETF
0.61%
Lattice Hartford Multifactor Small Cap ETF
0.58%
Federated Hermes MDT Small Cap Core ETF
0.38%
Unusual Whales Subversive Democratic Trading ETF
0.37%
iShares US Small Cap Value Factor ETF
0.33%
Royce Quant Small-Cap Quality Value ETF
0.21%
Vanguard US Multifactor ETF
0.14%
VictoryShares Small Cap Free Cash Flow ETF
0.12%
Ver Mais
Cambria Micro and SmallCap Shareholder Yield ETF
Proporção1.13%
Invesco NASDAQ Future Gen 200 ETF
Proporção0.61%
First Trust Active Factor Small Cap ETF
Proporção0.61%
Lattice Hartford Multifactor Small Cap ETF
Proporção0.58%
Federated Hermes MDT Small Cap Core ETF
Proporção0.38%
Unusual Whales Subversive Democratic Trading ETF
Proporção0.37%
iShares US Small Cap Value Factor ETF
Proporção0.33%
Royce Quant Small-Cap Quality Value ETF
Proporção0.21%
Vanguard US Multifactor ETF
Proporção0.14%
VictoryShares Small Cap Free Cash Flow ETF
Proporção0.12%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI